Literature DB >> 22728273

A novel denaturing heteroduplex tracking assay for genotypic prediction of HIV-1 tropism.

Binshan Shi1, Barbara Weiser, Linda M Styer, Kimdar Kemal, Cheryl Brunner, Kathryn Anastos, Harold Burger.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is characterized by sequence variability. The third variable region (V3) of the HIV-1 envelope glycoprotein gp120 plays a key role in determination of viral coreceptor usage (tropism) and pathogenesis. This report describes a novel denaturing heteroduplex tracking assay (HTA) to analyze the genetic variation of HIV-1 V3 DNA. It improved upon previous non-denaturing HTA approaches to distinguish HIV-1 CCR5 and CXCR4 tropic viruses in mixed populations. The modifications included the use of a single-stranded fluorescent probe based on the consensus V3 sequence of HIV-1 CCR5 tropic viruses, Locked Nucleic Acid (LNA) "clamps" at both ends of heteroduplex DNA, and denaturing gel electrophoresis using Mutation Detection Enhancement (MDE(®)) as matrix. The analysis demonstrated that the LNA "clamps" increased its melting temperature (T(m)) and the thermal stability of heteroduplex DNA. The partially denaturing gel used a defined concentration of formamide, and significantly induced mobility shifts of heteroduplex DNA that was dependent on the number and patterns of DNA mismatches and insertions/deletions. This new technique successfully detected tropisms of 53 HIV-1 V3 clones of known tropism, and was able to separate and detect multiple V3 DNA variants encoding tropisms for CCR5 or CXCR4 in a mixture. The assay had the sensitivity to detect 0.5% minority species. This method may be useful as a research tool for analysis of viral quasispecies and for genotypic prediction of HIV-1 tropism in clinical specimens.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728273      PMCID: PMC3417067          DOI: 10.1016/j.jviromet.2012.06.013

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  40 in total

1.  Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.

Authors:  Stephanie A Freel; Susan A Fiscus; Christopher D Pilcher; Prema Menezes; Julieta Giner; Ericka Patrick; Jeffrey L Lennox; Charles B Hicks; Joseph J Eron; Diane C Shugars
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

2.  Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.

Authors:  Rachel A McGovern; Alexander Thielen; Theresa Mo; Winnie Dong; Conan K Woods; Douglass Chapman; Marilyn Lewis; Ian James; Jayvant Heera; Hernan Valdez; P Richard Harrigan
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

3.  The contrasting structures of mismatched DNA sequences containing looped-out bases (bulges) and multiple mismatches (bubbles).

Authors:  A Bhattacharyya; D M Lilley
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

4.  Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.

Authors:  R Shankarappa; J B Margolick; S J Gange; A G Rodrigo; D Upchurch; H Farzadegan; P Gupta; C R Rinaldo; G H Learn; X He; X L Huang; J I Mullins
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

Authors:  W Resch; N Hoffman; R Swanstrom
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

6.  Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.

Authors:  S Philpott; B Weiser; K Anastos; C M Kitchen; E Robison; W A Meyer; H S Sacks; U Mathur-Wagh; C Brunner; H Burger
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Association of race and gender with HIV-1 RNA levels and immunologic progression.

Authors:  K Anastos; S J Gange; B Lau; B Weiser; R Detels; J V Giorgi; J B Margolick; M Cohen; J Phair; S Melnick; C R Rinaldo; A Kovacs; A Levine; S Landesman; M Young; A Muñoz; R M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

Review 8.  LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.

Authors:  Birte Vester; Jesper Wengel
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

9.  HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.

Authors:  Kimdar Sherefa Kemal; Brian Foley; Harold Burger; Kathryn Anastos; Howard Minkoff; Christina Kitchen; Sean M Philpott; Wei Gao; Esther Robison; Susan Holman; Carolyn Dehner; Suzanne Beck; William A Meyer; Alan Landay; Andrea Kovacs; James Bremer; Barbara Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

10.  Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.

Authors:  Mark A Jensen; Fu-Sheng Li; Angélique B van 't Wout; David C Nickle; Daniel Shriner; Hong-Xia He; Sherry McLaughlin; Raj Shankarappa; Joseph B Margolick; James I Mullins
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more
  3 in total

1.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

2.  A diagnostic HIV-1 tropism system based on sequence relatedness.

Authors:  Suzanne Edwards; Heinz Stucki; Joëlle Bader; Vincent Vidal; Rolf Kaiser; Manuel Battegay; Thomas Klimkait
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

3.  A simple genotyping method to detect small CRISPR-Cas9 induced indels by agarose gel electrophoresis.

Authors:  Debanjan Bhattacharya; Erwin G Van Meir
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.